These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 28492868

  • 1. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
    Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, Batra AS, Kaufman ES, Fairbrother DL, Saarel EV, Etheridge SP, Kanter RJ, Carboni MP, Dzurik MV, Fountain D, Chen H, Ely EW, Roden DM, Knollmann BC.
    JAMA Cardiol; 2017 Jul 01; 2(7):759-766. PubMed ID: 28492868
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
    van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A, Shimizu W, Sumitomo N, Fish FA, Bhuiyan ZA, Willems AR, van der Veen MJ, Watanabe H, Laborderie J, Haïssaguerre M, Knollmann BC, Wilde AA.
    J Am Coll Cardiol; 2011 May 31; 57(22):2244-54. PubMed ID: 21616285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
    Pott C, Dechering DG, Reinke F, Muszynski A, Zellerhoff S, Bittner A, Köbe J, Wasmer K, Schulze-Bahr E, Mönnig G, Kotthoff S, Eckardt L.
    Europace; 2011 Jun 31; 13(6):897-901. PubMed ID: 21292648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.
    Wangüemert Pérez F, Hernández Afonso JS, Groba Marco MDV, Caballero Dorta E, Álvarez Acosta L, Campuzano Larrea O, Pérez G, Brugada Terradellas J, Brugada Terradellas R.
    Rev Esp Cardiol (Engl Ed); 2018 Mar 31; 71(3):185-191. PubMed ID: 28789916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.
    Hong RA, Rivera KK, Jittirat A, Choi JJ.
    Pacing Clin Electrophysiol; 2012 Jul 31; 35(7):794-7. PubMed ID: 22553997
    [Abstract] [Full Text] [Related]

  • 11. In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia.
    Yang PC, Moreno JD, Miyake CY, Vaughn-Behrens SB, Jeng MT, Grandi E, Wehrens XH, Noskov SY, Clancy CE.
    J Physiol; 2016 Feb 01; 594(3):567-93. PubMed ID: 26515697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Claudio B, Alice M, Daniel S.
    Mini Rev Med Chem; 2018 Feb 01; 18(6):476-482. PubMed ID: 28685702
    [Abstract] [Full Text] [Related]

  • 14. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S.
    Heart Rhythm; 2007 Sep 01; 4(9):1149-54. PubMed ID: 17765612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Duan H, Lu Y, Yan S, Qiao L, Hua Y, Li Y, Zhou K, Wang C.
    Medicine (Baltimore); 2018 Apr 01; 97(16):e0368. PubMed ID: 29668588
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F, Jarman JW, Clague JR, Till J.
    Heart Rhythm; 2014 Jan 01; 11(1):58-66. PubMed ID: 24120999
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.
    Europace; 2010 Mar 01; 12(3):417-23. PubMed ID: 20106799
    [Abstract] [Full Text] [Related]

  • 19. Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy.
    Roston TM, Van Petegem F, Sanatani S.
    Curr Opin Cardiol; 2017 Jan 01; 32(1):78-85. PubMed ID: 27861184
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.